Photo taken Sandra Algarín-Perneth/Twitter
Oct 28, 2023, 03:09
Sandra Algarín-Perneth: The success of precision oncology guided by HER2 genomic profiling – a rare neuroendocrine carcinoma case
Sandra Algarín-Perneth, Postdoctoral Research Fellow in Gastroenterology and Hepatology at Mayo Clinic, shared on Twitter:
“Explore a rare neuroendocrine carcinoma case, demonstrating the success of precision oncology guided by HER2 genomic profiling. This emphasizes innovative treatments and advocates for broader HER2-positive clinical trial inclusion.
Grateful for the incredible mentors guiding me through this case report. Their expertise and support have been invaluable in shaping this important work. ”
For the article click here.
Source: Sandra Algarín-Perneth/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59